Preparative Biochemistry and Biotechnology 2005-01-01

Efficient production of recombinant aldehyde reductase and its application for asymmetric reduction of ethyl 4-chloro-3-oxobutanoate to ethyl (R)-4-chloro-3-hydroxybutanoate.

Keju Jing, Zhinan Xu, Ying Liu, Xiaoxia Jiang, Li Peng, Peilin Cen

Index: Prep Biochem Biotechnol. 35(3) , 203-15, (2005)

Full Text: HTML

Abstract

An NADPH-dependent aldehyde reductase (ALR, EC1.1.1.2) gene is cloned from Sporobolomyces salmonicolor ZJUB 105, and inserted into plasmid pQE30 to construct the expression plasmid (pQE30-ALR). A variety of E. coli strains were employed as hosts to obtain transformants with pQE30-ALR, respectively. Among these different types of transformants, the highest enzyme activity of ALR can be produced with E. coli M15 (pQE30-ALR). The bioactivity of ALR could be further improved significantly by the optimization of induction conditions. The results showed that the enzyme activity of ALR reached 6.48 U/mg protein, which is fifteen times higher than that of S. salmonicolor ZJUB 105. This recombinant strain was applied to the asymmetric reduction of ethyl 4-chloro-3-oxobutanoate (COBE) to ethyl (R)-4-chloro-3- hydroxybutanoate (CHBE). The results showed that the yield and optical purity of (R)-CHBE reached 98.5% and 99% e.e. (enantiomeric excess), respectively.


Related Compounds

Related Articles:

Construction of a two-strain system for asymmetric reduction of ethyl 4-chloro-3-oxobutanoate to (S)-4-chloro-3-hydroxybutanoate ethyl ester.

2006-03-01

[Appl. Microbiol. Biotechnol. 70(1) , 40-6, (2006)]

Purification and characterization of an alpha-haloketone-resistant formate dehydrogenase from Thiobacillus sp. strain KNK65MA, and cloning of the gene.

2003-10-01

[Biosci. Biotechnol. Biochem. 67(10) , 2145-53, (2003)]

A novel carbonyl reductase from Pichia stipitis for the production of ethyl (S)-4-chloro-3-hydroxybutanoate.

2009-04-01

[Biotechnol. Lett. 31(4) , 537-42, (2009)]

Biosimulation of drug metabolism—A yeast based model

2009-01-01

[Eur. J. Pharm. Sci. 36(1) , 157-70, (2009)]

Enantioselective bioconversion using Escherichia coli cells expressing Saccharomyces cerevisiae reductase and Bacillus subtilis glucose dehydrogenase.

2010-09-01

[J. Microbiol. Biotechnol. 20(9) , 1300-6, (2010)]

More Articles...